Увійти

Готові списки джерел за темами / Ultrasound drug delivery

Зміст

Статті в журналах
Дисертації
Книги
Частини книг
Тези доповідей конференцій

Добірка наукової літератури з теми "Ultrasound drug delivery"

Автор: Grafiati

Опубліковано: 31 серпня 2024

Оформте джерело за APA, MLA, Chicago, Harvard та іншими стилями

Оберіть тип джерела:

Ознайомтеся зі списками актуальних статей, книг, дисертацій, тез та інших наукових джерел на тему "Ultrasound drug delivery".

Біля кожної праці в переліку літератури доступна кнопка «Додати до бібліографії». Скористайтеся нею – і ми автоматично оформимо бібліографічне посилання на обрану працю в потрібному вам стилі цитування: APA, MLA, «Гарвард», «Чикаго», «Ванкувер» тощо.

Також ви можете завантажити повний текст наукової публікації у форматі «.pdf» та прочитати онлайн анотацію до роботи, якщо відповідні параметри наявні в метаданих.

Статті в журналах з теми "Ultrasound drug delivery"

1

Postema, Michiel, and Odd Gilja. "Ultrasound-Directed Drug Delivery." Current Pharmaceutical Biotechnology 8, no. 6 (December 1, 2007): 355–61. http://dx.doi.org/10.2174/138920107783018453.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

2

Goertz, David, and Kullervo Hynynen. "Ultrasound-mediated drug delivery." Physics Today 69, no. 3 (March 2016): 30–36. http://dx.doi.org/10.1063/pt.3.3106.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

3

Sonis, ST. "Ultrasound-mediated drug delivery." Oral Diseases 23, no. 2 (June 29, 2016): 135–38. http://dx.doi.org/10.1111/odi.12501.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

4

Pua, E. C., and Pei Zhong. "Ultrasound-mediated drug delivery." IEEE Engineering in Medicine and Biology Magazine 28, no. 1 (January 2009): 64–75. http://dx.doi.org/10.1109/memb.2008.931017.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

5

Moonen, Chrit, and Ine Lentacker. "Ultrasound assisted drug delivery." Advanced Drug Delivery Reviews 72 (June 2014): 1–2. http://dx.doi.org/10.1016/j.addr.2014.04.002.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

6

Zderic, Vesna. "Ultrasound enhanced ocular drug delivery." Journal of the Acoustical Society of America 153, no. 3_supplement (March 1, 2023): A67. http://dx.doi.org/10.1121/10.0018185.

Повний текст джерела

Анотація:

Our objective has been to determine ultrasound parameters that can provide optimal delivery of different drugs into the eye via transcorneal and transscleral routes, study mechanisms of ultrasound action, and determine long-term safety of this approach. We showed previously that exposing cornea to therapeutic ultrasound can lead to up to 10 times more delivery of a drug-mimicking compound into the eye, with only minimal alterations in the corneal structure. Subsequently, we continued to work on drug delivery problems with clinical relevance, such as promoting delivery of antibiotics and steroids for treatment of eye inflammations. Our studies also included modeling of temperature increases in the eye during ultrasound application, effectiveness and safety of delivery of an anti-parasitic drug PHMB into the eye, and delivery of macromolecules such as Avastin via transscleral route for treatment of mascular degeneration. Our research work showed that ultrasound application can be effective and safe for delivery of drugs of different molecular sizes into the eye in vitro and in vivo. This work may eventually lead to development of an inexpensive, and non-invasive ultrasound method that can be applied in an outpatient clinic to allow targeted delivery of medications for treatment of different ocular diseases.

Стилі APA, Harvard, Vancouver, ISO та ін.

7

Daftardar, Saloni, Rabin Neupane, Sai HS Boddu, Jwala Renukuntla, and Amit K. Tiwari. "Advances in Ultrasound Mediated Transdermal Drug Delivery." Current Pharmaceutical Design 25, no. 4 (June 3, 2019): 413–23. http://dx.doi.org/10.2174/1381612825666190211163948.

Повний текст джерела

Анотація:

Low frequency ultrasound-assisted drug delivery has been widely investigated as a non-invasive method to enhance the transdermal penetration of drugs. Using this technique, a brief application of ultrasound is used to permeabilize skin for a prolonged time. In this review, an overview on ultrasound is detailed to help explain the parameters that could be modulated to obtain the desired ultrasound parameters for enhanced transdermal drug delivery. The mechanisms of enhancement and the latest developments in the area of ultrasound-assisted transdermal drug delivery are discussed. Special emphasis is placed on the effects of ultrasound when used in combination with microneedles, electroporation and iontophoresis, and penetration enhancers. Further, this review summarizes the effect of ultrasound on skin integrity and the regulatory requirements for commercialization of the ultrasound based transdermal delivery instruments.

Стилі APA, Harvard, Vancouver, ISO та ін.

8

Tezel, Ahmet, Ashley Sens, and Samir Mitragotri. "Ultrasound mediated transdermal drug delivery." Journal of the Acoustical Society of America 112, no. 5 (November 2002): 2337. http://dx.doi.org/10.1121/1.4779436.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

9

Zderic, Vesna, John I. Clark, Roy W. Martin, and Shahram Vaezy. "Ultrasound-Enhanced Transcorneal Drug Delivery." Cornea 23, no. 8 (November 2004): 804–11. http://dx.doi.org/10.1097/01.ico.0000134189.33549.cc.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

10

Holland, Christy K., Jonathan A. Kopechek, Kathryn Hitchcock, Jonathan Sutton, Danielle Caudell, Gail Pyne-Geithman, Shaoling Huang, and David D. McPherson. "0277: Ultrasound Mediated Drug Delivery." Ultrasound in Medicine & Biology 35, no. 8 (August 2009): S33. http://dx.doi.org/10.1016/j.ultrasmedbio.2009.06.127.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Більше джерел

Дисертації з теми "Ultrasound drug delivery"

1

Zderic, Vesna. "Ultrasound-enhanced ocular drug delivery /." Thesis, Connect to this title online; UW restricted, 2004. http://hdl.handle.net/1773/8085.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

2

Sutton, Jonathan T. "Tissue Bioeffects during Ultrasound-Mediated Drug Delivery." University of Cincinnati / OhioLINK, 2014. http://rave.ohiolink.edu/etdc/view?acc_num=ucin1397234692.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

3

Diaz, de la Rosa Mario Alfonso. "High-frequency ultrasound drug delivery and cavitation /." Diss., CLICK HERE for online access, 2007. http://contentdm.lib.byu.edu/ETD/image/etd1679.pdf.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

4

Diaz, Mario Alfonso. "High-Frequency Ultrasound Drug Delivery and Cavitation." BYU ScholarsArchive, 2007. https://scholarsarchive.byu.edu/etd/1050.

Повний текст джерела

Анотація:

The viability of a drug delivery system which encapsulates chemotherapeutic drugs (Doxorubicin) in the hydrophobic core of polymeric micelles and triggers release by ultrasound application was investigated at an applied frequency of 500 kHz. The investigation also included elucidating the mechanism of drug release at 70 kHz, a frequency which had previously been shown to induce drug release. A fluorescence detection chamber was used to measure in vitro drug release from both Pluronic and stabilized micelles and a hydrophone was used to monitor bubble activity during the experiments. A threshold for release between 0.35 and 0.40 in mechanical index was found at 70 kHz and shown to correspond with the appearance of the subharmonic signal in the acoustic spectrum. Additionally, drug release was found to correlate with increase in subharmonic emission. No evidence of drug release or of the subharmonic signal was detected at 500 kHz. These findings confirmed the role of cavitation in ultrasonic drug release from micelles. A mathematical model of a bubble oscillator was solved to explore the differences in the behavior of a single 10 um bubble under 70 and 500 kHz ultrasound. The dynamics were found to be fundamentally different; the bubble follows a period-doubling route to chaos at 500 kHz and an intermittent route to chaos at 70 kHz. It was concluded that this type of "intermittent subharmonic" oscillation is associated with the apparent drug release. This research confirmed the central role of cavitation in ultrasonically-triggered drug delivery from micelles, established the importance of subharmonic bubble oscillations as an indicator, and expounded the key dynamic differences between 70 and 500 kHz ultrasonic cavitation.

Стилі APA, Harvard, Vancouver, ISO та ін.

5

Mualem-Burstein, Odelia Wheatley Margaret A. "Drug loading onto polymeric contrast agents for ultrasound drug delivery /." Philadelphia, Pa. : Drexel University, 2008. http://hdl.handle.net/1860/2811.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

6

Dwaikat, Mai Al. "The Effect of Ultrasound on Transdermal Drug Delivery." Thesis, Coventry University, 2007. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.492372.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

7

Mitragotri, Samir. "Ultrasound-mediated transdermal drug delivery : mechanisms and applications." Thesis, Massachusetts Institute of Technology, 1996. http://hdl.handle.net/1721.1/11263.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

8

Fowler, Robert Andrew. "Inertial Cavitation with Confocal Ultrasound for Drug Delivery." Thesis, Lyon 1, 2014. http://www.theses.fr/2014LYO10024.

Повний текст джерела

Анотація:

Il a été montré que la cavitation acoustique pouvait se révéler utile dans l'administration de médicaments pour de nombreuses applications biologiques et médicales. Cette thèse commence par une présentation de la cavitation ultrasonore et des mécanismes d'action mis en jeu pour la délivrance de médicaments. A la fin de ce cette synthèse, un dispositif à deux transducteurs ultrasonores disposés de manière confocale est présenté pour résoudre certains des problèmes actuels dans le domaine. Il est ensuite mis en oeuvre dans différentes études de faisabilité. La thèse est organisée en 5 chapitres : 1. L'utilisation de la cavitation acoustique dans un contexte biomédical est présentée ici dans une revue générale. Ce chapitre comprend l'état de l'art pour la génération de cavitation, les techniques expérimentales qui sont actuellement mises en oeuvre pour la mesure de la cavitation, et les approches cliniques et précliniques pour l'utilisation de la cavitation in vivo pour différents types de tissu biologique. 2. Le dispositif ultrasonore utilisé pour toutes les études de cette thèse est ensuite décrit. Il est caractérisé acoustiquement et comparé avec un simple transducteur dans le but de démontrer son efficacité pour la génération de la cavitation. Cette comparaison est d'abord faite par une quantification chimique du niveau de cavitation. A puissance constante, le dispositif à deux transducteurs confocaux est bien plus efficace pour générer de la cavitation. Les causes de cette observation, notamment la réduction de la propagation non-linéaire et la stabilisation du nuage des bulles par les forces Bjerknes, sont ensuite étudiées par des mesures acoustiques, des simulations de pression en régime linéaire et un suivi par une caméra ultra rapide des nuages de bulles induits. 3. Le prototype confocal est utilisé in vivo sur des tumeurs sous cutanées en conjonction avec des liposomes. Dans un premier temps, des essais sous IRM démontrent la possibilité de larguer le contenu des liposomes localement par la cavitation inertielle délivrée par le dispositif. Une seconde étude avec une formulation liposomale de doxorubicine a permis de démontrer l'amélioration de la réponse thérapeutique de la chimiothérapie après application de la cavitation inertielle.. 4. Une étude de faisabilité de l'interférence de l'ARN (RNAi) sur un petit nombre d'animaux est réalisée avec le dispositif confocal et des molécules de siRNA encapsulées dans des liposomes Les expériences sont conduites in vivo avec une xénogreffe de tumeur de sein humain. Après une phase de réglage des paramètres ultrasonores pour limiter la toxicité du traitement, on observe une inhibition significative du gène ciblé. 5. Une deuxième étude de faisabilité est réalisée pour étudier la potentialisation de la chimiothérapie avec l'évérolimus dans un modèle de chondrosarcome de rat. Les traitements ultrasonores et les chimiothérapies sont répétés. Sur un petit nombre d'animaux, on montre l'innocuité du traitement ultrasonore, et l'efficacité en conjonction avec l'agent anti tumoraux, évérolimus
Acoustic cavitation has been shown to be a useful tool in drug delivery for many different biological tissues and indications, and this thesis aims to contribute to the knowledge of cavitation from a drug delivery perspective. This thesis seeks to synthesize the current knowledge and practice concerning acoustic cavitation in a biomedical context, and to present a high intensity confocal ultrasound (US) prototype to address some of the current problems in the field and to give a proof of concept for the therapeutic efficacy of such a prototype. The thesis is organized in 5 chapters: 1. The use of acoustic cavitation in a biomedical context is presented here in a general review. This review comprises the state of the art for cavitation generation, experimental techniques currently being implemented for the measurement of cavitation, and the clinical and preclinical approaches to the use of cavitation in vivo on a tissue by tissue basis. 2. The high intensity confocal US prototype used for all studies in this thesis is presented here. It is characterized in terms of the advantages it gives for the generation of cavitation. Enhancement of cavitation is first demonstrated chemometrically with a fluorescent dosimeter compared to a single transducer at the ultrasonic focus. The mechanisms for cavitation enhancement are then investigated with acoustic measurements, linear pressure simulations, and high speed camera data. 3. The confocal US prototype in used in conjunction with a liposomal formulation of doxorubicin is performed in which a therapeutic enhancement of tumor inhibition is presented. The mechanism of this enhancement is investigated with liposomally encapsulated lanthanide contrast agents and magnetic resonance imaging. 4. A small scale proof of concept for the use of RNA interference using the confocal prototype, and liposomally encapsulated siRNA molecules. The experiments are performed In vivo with a xenograft of human breast tumor. This study also includes data for the safety of the US exposure on a mouse treated one time. 5. Another small scale proof of concept of the use of the confocal device on potentiating chemotherapy with the drug everolimus in a rat chondrosarcoma model. The studies presented here also investigate the use of multiple US exposures on the same tumor in a combined drug / US treatment regimen

Стилі APA, Harvard, Vancouver, ISO та ін.

9

Fowler, Robert Andrew. "Inertial Cavitation with Confocal Ultrasound for Drug Delivery." Electronic Thesis or Diss., Lyon 1, 2014. http://www.theses.fr/2014LYO10024.

Повний текст джерела

Анотація:

Il a été montré que la cavitation acoustique pouvait se révéler utile dans l'administration de médicaments pour de nombreuses applications biologiques et médicales. Cette thèse commence par une présentation de la cavitation ultrasonore et des mécanismes d'action mis en jeu pour la délivrance de médicaments. A la fin de ce cette synthèse, un dispositif à deux transducteurs ultrasonores disposés de manière confocale est présenté pour résoudre certains des problèmes actuels dans le domaine. Il est ensuite mis en oeuvre dans différentes études de faisabilité. La thèse est organisée en 5 chapitres : 1. L'utilisation de la cavitation acoustique dans un contexte biomédical est présentée ici dans une revue générale. Ce chapitre comprend l'état de l'art pour la génération de cavitation, les techniques expérimentales qui sont actuellement mises en oeuvre pour la mesure de la cavitation, et les approches cliniques et précliniques pour l'utilisation de la cavitation in vivo pour différents types de tissu biologique. 2. Le dispositif ultrasonore utilisé pour toutes les études de cette thèse est ensuite décrit. Il est caractérisé acoustiquement et comparé avec un simple transducteur dans le but de démontrer son efficacité pour la génération de la cavitation. Cette comparaison est d'abord faite par une quantification chimique du niveau de cavitation. A puissance constante, le dispositif à deux transducteurs confocaux est bien plus efficace pour générer de la cavitation. Les causes de cette observation, notamment la réduction de la propagation non-linéaire et la stabilisation du nuage des bulles par les forces Bjerknes, sont ensuite étudiées par des mesures acoustiques, des simulations de pression en régime linéaire et un suivi par une caméra ultra rapide des nuages de bulles induits. 3. Le prototype confocal est utilisé in vivo sur des tumeurs sous cutanées en conjonction avec des liposomes. Dans un premier temps, des essais sous IRM démontrent la possibilité de larguer le contenu des liposomes localement par la cavitation inertielle délivrée par le dispositif. Une seconde étude avec une formulation liposomale de doxorubicine a permis de démontrer l'amélioration de la réponse thérapeutique de la chimiothérapie après application de la cavitation inertielle.. 4. Une étude de faisabilité de l'interférence de l'ARN (RNAi) sur un petit nombre d'animaux est réalisée avec le dispositif confocal et des molécules de siRNA encapsulées dans des liposomes Les expériences sont conduites in vivo avec une xénogreffe de tumeur de sein humain. Après une phase de réglage des paramètres ultrasonores pour limiter la toxicité du traitement, on observe une inhibition significative du gène ciblé. 5. Une deuxième étude de faisabilité est réalisée pour étudier la potentialisation de la chimiothérapie avec l'évérolimus dans un modèle de chondrosarcome de rat. Les traitements ultrasonores et les chimiothérapies sont répétés. Sur un petit nombre d'animaux, on montre l'innocuité du traitement ultrasonore, et l'efficacité en conjonction avec l'agent anti tumoraux, évérolimus
Acoustic cavitation has been shown to be a useful tool in drug delivery for many different biological tissues and indications, and this thesis aims to contribute to the knowledge of cavitation from a drug delivery perspective. This thesis seeks to synthesize the current knowledge and practice concerning acoustic cavitation in a biomedical context, and to present a high intensity confocal ultrasound (US) prototype to address some of the current problems in the field and to give a proof of concept for the therapeutic efficacy of such a prototype. The thesis is organized in 5 chapters: 1. The use of acoustic cavitation in a biomedical context is presented here in a general review. This review comprises the state of the art for cavitation generation, experimental techniques currently being implemented for the measurement of cavitation, and the clinical and preclinical approaches to the use of cavitation in vivo on a tissue by tissue basis. 2. The high intensity confocal US prototype used for all studies in this thesis is presented here. It is characterized in terms of the advantages it gives for the generation of cavitation. Enhancement of cavitation is first demonstrated chemometrically with a fluorescent dosimeter compared to a single transducer at the ultrasonic focus. The mechanisms for cavitation enhancement are then investigated with acoustic measurements, linear pressure simulations, and high speed camera data. 3. The confocal US prototype in used in conjunction with a liposomal formulation of doxorubicin is performed in which a therapeutic enhancement of tumor inhibition is presented. The mechanism of this enhancement is investigated with liposomally encapsulated lanthanide contrast agents and magnetic resonance imaging. 4. A small scale proof of concept for the use of RNA interference using the confocal prototype, and liposomally encapsulated siRNA molecules. The experiments are performed In vivo with a xenograft of human breast tumor. This study also includes data for the safety of the US exposure on a mouse treated one time. 5. Another small scale proof of concept of the use of the confocal device on potentiating chemotherapy with the drug everolimus in a rat chondrosarcoma model. The studies presented here also investigate the use of multiple US exposures on the same tumor in a combined drug / US treatment regimen

Стилі APA, Harvard, Vancouver, ISO та ін.

10

Phan, Tu-Ai Thi. "Novel host-guest systems for ultrasound-mediated drug delivery /." Available to subscribers only, 2007. http://proquest.umi.com/pqdweb?did=1459908051&sid=2&Fmt=2&clientId=1509&RQT=309&VName=PQD.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Більше джерел

Книги з теми "Ultrasound drug delivery"

1

Field, Rachel Diane. Ultrasound-Responsive Microcapsules for Localized Drug Delivery Applications. [New York, N.Y.?]: [publisher not identified], 2022.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

2

Downs, Matthew. Focused Ultrasound Mediated Blood-Brain Barrier Opening in Non-Human Primates: Safety, Efficacy and Drug Delivery. [New York, N.Y.?]: [publisher not identified], 2015.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

3

Samiotaki, Gesthimani. Quantitative and dynamic analysis of the focused-ultrasound induced blood-brain barrier opening in vivo for drug delivery. [New York, N.Y.?]: [publisher not identified], 2015.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

4

Yan, Fei, Jean Jose, and Xiaobing Wang, eds. Ultrasound for Precision Medicine: Diagnosis, Drug Delivery and Image-Guided Therapy. Frontiers Media SA, 2020. http://dx.doi.org/10.3389/978-2-88963-735-5.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

5

Waje-Andreassen, Ulrike, and Nicola Logallo. Vascular imaging: Ultrasound. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780198722366.003.0009.

Повний текст джерела

Анотація:

After computed tomography and computed tomography angiography or magnetic resonance imaging and magnetic resonance angiography at admission, ultrasound is the most important diagnostic tool to confirm angiographic findings and to closely follow-up patients until the clinical situation has stabilized. Thrombolysis and interventional therapy have given transcranial ultrasound a very important role in bedside monitoring of occlusions, collaterals, cerebral haemodynamics, and vasoreactivity. Detection of flow changes in sickle cell disease, circulating emboli, and right-to-left shunts may guide treatment decisions. Sonothrombolysis and targeted drug delivery are today’s research projects for acute treatment by ultrasound. Extracranial cerebrovascular ultrasound is an ‘all-round’ diagnostic tool modifying angiographic results, showing minor arterial wall disease, plaques, and plaque instability. Microembolic signals during scanning may contribute to finding the cause of stroke. In stroke prevention, ultrasound delivers the possibility for staging of arteries and improving targeted intervention. Ultrasound images may also serve as educational tools for patients to underline the need for continuous medical treatment and lifestyle changes, and may improve compliance.

Стилі APA, Harvard, Vancouver, ISO та ін.

6

Bhaskar, Arun. Endoscopic ultrasound-guided coeliac plexus block. Edited by Paul Farquhar-Smith, Pierre Beaulieu, and Sian Jagger. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780198834359.003.0064.

Повний текст джерела

Анотація:

The landmark paper discussed in this chapter is ‘Endosonography-guided celiac plexus neurolysis’, published by Wiersema and Wiersema in 1996. Pain is one of its most distressing complaints of pancreatic cancer, affecting more than 80% of patients with advanced disease. However, the use of opioids and other drugs is often limited by undesirable side effects, which include somnolence, confusion, lethargy, and decreased cognitive function. Intrathecal drug delivery systems, although effective, are often deemed impractical in pancreatic cancer, due to its poor prognosis and the fact that it is often diagnosed late. Tumour infiltration of the coeliac plexus results in pain in the abdomen and back; thus, this area has often been targeted for analgesia via a neurolytic coeliac plexus block. The paper by Wiersema and Wiersema examines the efficacy of an approach that uses ultrasound to guide needle placement in celiac plexus neurolysis, in a study of 30 patients.

Стилі APA, Harvard, Vancouver, ISO та ін.

7

Paul, Richard. Ultrasound-guided vascular access in intensive/acute cardiac care. Oxford University Press, 2015. http://dx.doi.org/10.1093/med/9780199687039.003.0021.

Повний текст джерела

Анотація:

Vascular access is an essential requirement for the care of the critically ill cardiac patient, being necessary for drug and fluid delivery and monitoring of a patient’s haemodynamic response to an instigated therapy. The most common vascular access procedures conducted in the acute cardiac care unit are central venous and peripheral venous access, and arterial cannulation. Traditional landmark methods are associated with complication rates, ranging from 18 to 40%, depending on the site of access. The use of ultrasound to guide venous and arterial access has been shown to reduce the incidence of complications, such as inadvertent arterial puncture and pneumothorax formation (venous) and posterior wall puncture (arterial), to reduce the time taken and number of attempts to place a catheter, and to reduce the incidence of complete failure to insert a vascular access device. Since 2002, international consensus groups have published recommendations that two-dimensional ultrasound guidance be the preferred method for elective and emergency internal jugular catheter insertion. This chapter explores the evidence for the use of ultrasound to guide vascular access across multiple sites of insertion and describes the basic equipment and techniques necessary for successful deployment.

Стилі APA, Harvard, Vancouver, ISO та ін.

8

Bendel, Markus A., Drew M. Trainor, and Susan M. Moeschler. Imaging. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780190217518.003.0006.

Повний текст джерела

Анотація:

This chapter focuses on diagnostic and procedural imaging techniques that are essential for the pain medicine practitioner. Attention is given to most modern imaging modalities, including ultrasonography, fluoroscopy, computed tomography, and magnetic resonance imaging. The chapter includes a review of many advanced pain medicine procedures, such as celiac plexus and stellate ganglion blocks. A discussion regarding the use of imaging to elucidate a problem with an implanted intrathecal drug delivery system is included as well. In addition to the procedure suite, this chapter provides a review of common radiological findings that are critical for the proper diagnosis and management of pain patients, including spondylolysis and Modic changes. Special attention is paid to the use of ultrasound in pain medicine, including diagnostic techniques in musculoskeletal disorders. Many questions contain a review of the significant anatomic considerations with each procedural technique.

Стилі APA, Harvard, Vancouver, ISO та ін.

Частини книг з теми "Ultrasound drug delivery"

1

Ng, Ka-Yun, and Terry O. Matsunaga. "Ultrasound-Mediated Drug Delivery." In Drug Delivery, 245–78. Hoboken, NJ, USA: John Wiley & Sons, Inc., 2005. http://dx.doi.org/10.1002/0471475734.ch12.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

2

Ibsen, Stuart, Michael Benchimol, Dmitri Simberg, and Sadik Esener. "Ultrasound Mediated Localized Drug Delivery." In Nano-Biotechnology for Biomedical and Diagnostic Research, 145–53. Dordrecht: Springer Netherlands, 2011. http://dx.doi.org/10.1007/978-94-007-2555-3_14.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

3

Kost, Joseph, and Robert Langer. "Ultrasound-Mediated Transdermal Drug Delivery." In Topical Drug Bioavailability, Bioequivalence, and Penetration, 91–104. Boston, MA: Springer US, 1993. http://dx.doi.org/10.1007/978-1-4899-1262-6_4.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

4

Morse, Sophie V., Tiffany G. Chan, Javier Cudeiro-Blanco, and Antonios N. Pouliopoulos. "Ultrasound-Mediated Delivery of Therapeutics." In Emerging Drug Delivery and Biomedical Engineering Technologies, 181–93. Boca Raton: CRC Press, 2023. http://dx.doi.org/10.1201/9781003224464-12.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

5

Mitragotri, Samir. "Sonophoresis: Ultrasound-Mediated Transdermal Drug Delivery." In Percutaneous Penetration Enhancers Physical Methods in Penetration Enhancement, 3–14. Berlin, Heidelberg: Springer Berlin Heidelberg, 2017. http://dx.doi.org/10.1007/978-3-662-53273-7_1.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

6

Xia, Hesheng, Yue Zhao, and Rui Tong. "Ultrasound-Mediated Polymeric Micelle Drug Delivery." In Advances in Experimental Medicine and Biology, 365–84. Cham: Springer International Publishing, 2016. http://dx.doi.org/10.1007/978-3-319-22536-4_20.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

7

O’Reilly, Meaghan A., and Kullervo Hynynen. "Ultrasound and Microbubble-Mediated Blood-Brain Barrier Disruption for Targeted Delivery of Therapeutics to the Brain." In Targeted Drug Delivery, 111–19. New York, NY: Springer US, 2018. http://dx.doi.org/10.1007/978-1-4939-8661-3_9.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

8

Rapoport, Natalya. "Drug-Loaded Perfluorocarbon Nanodroplets for Ultrasound-Mediated Drug Delivery." In Advances in Experimental Medicine and Biology, 221–41. Cham: Springer International Publishing, 2016. http://dx.doi.org/10.1007/978-3-319-22536-4_13.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

9

Gourevich, D., and S. Cochran. "CHAPTER 7. Targeted Delivery with Ultrasound Activated Nano-encapsulated Drugs." In Drug Discovery, 164–81. Cambridge: Royal Society of Chemistry, 2018. http://dx.doi.org/10.1039/9781788010597-00164.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

10

Konofagou, Elisa E. "Optimization of Blood-Brain Barrier Opening with Focused Ultrasound: The Animal Perspective." In Drug Delivery to the Brain, 607–28. Cham: Springer International Publishing, 2022. http://dx.doi.org/10.1007/978-3-030-88773-5_20.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Тези доповідей конференцій з теми "Ultrasound drug delivery"

1

Zderic, Vesna. "Ocular Drug Delivery Using Ultrasound." In 4TH INTERNATIONAL SYMPOSIUM ON THERAPEUTIC ULTRASOUND. AIP, 2005. http://dx.doi.org/10.1063/1.1901614.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

2

Benchimol, Michael J., Mark J. Hsu, Carolyn E. Schutt, and Sadik C. Esener. "Ultrasound-Quenchable Fluorescent Contrast Agent: Experimental Demonstration." In Optical Molecular Probes, Imaging and Drug Delivery. Washington, D.C.: OSA, 2011. http://dx.doi.org/10.1364/omp.2011.omd2.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

3

Bozhko, Dmitry, Eric A. Osborn, Amir Rosenthal, Johan W. H. Verjans, Tetsuya Hara, Jason R. McCarthy, Stephan Kellnberger, et al. "Quantitative Intravascular Fluorescence-Ultrasound Imaging In Vivo." In Optical Molecular Probes, Imaging and Drug Delivery. Washington, D.C.: OSA, 2017. http://dx.doi.org/10.1364/omp.2017.omm2d.3.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

4

Yu, Shuai, Yuan Liu, Jayanth Kandukuri, Tingfeng Yao, and Baohong Yuan. "Near-infrared time-domain ultrasound-switchable fluorescence imaging." In Optical Molecular Probes, Imaging and Drug Delivery. Washington, D.C.: OSA, 2017. http://dx.doi.org/10.1364/omp.2017.omm2d.2.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

5

Jandhyala, Sidhartha, and Geoffrey P. Luke. "Optically Activated Oxygen-Loaded Perfluorocarbon Nanoparticles for Ultrasound-guided Radiation Therapy." In Optical Molecular Probes, Imaging and Drug Delivery. Washington, D.C.: OSA, 2017. http://dx.doi.org/10.1364/omp.2017.omw3d.7.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

6

Wang, Joy, Pradyumna Kedarisetti, Matthew G. Mallay, Jeremy A. Brown, Frank R. Wuest, and Roger J. Zemp. "Ultrasound and Photoacoustic Image-Guided Micro-Histotripsy for Non-Invasive Surgery." In Optical Molecular Probes, Imaging and Drug Delivery. Washington, D.C.: Optica Publishing Group, 2023. http://dx.doi.org/10.1364/omp.2023.otu1e.3.

Повний текст джерела

Анотація:

Histotripsy is a powerful precision tool for non-invasive, non-ionizing treatment of tumors, but suffers risk of damage to vasculature under poor visualization. Photoacoustic-guided histotripsy allows for visualization and avoidance of major vasculature and hemorrhage monitoring.

Стилі APA, Harvard, Vancouver, ISO та ін.

7

Treat, Lisa Hsu. "Targeted Drug Delivery to the Brain by MRI-guided Focused Ultrasound." In THERAPEUTIC ULTRASOUND: 5th International Symposium on Therapeutic Ultrasound. AIP, 2006. http://dx.doi.org/10.1063/1.2205479.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

8

Moothanchery, Mohesh, Razina Z. Seeni, Chenjie Xu, and Manojit Pramanik. "Photoacoustic microscopy imaging for microneedle drug delivery." In Photons Plus Ultrasound: Imaging and Sensing 2018, edited by Alexander A. Oraevsky and Lihong V. Wang. SPIE, 2018. http://dx.doi.org/10.1117/12.2287837.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

9

Kooiman, Klazina, Marcia Emmer, Miranda Harteveld, Nico De Jong, and Annemieke Van Wamel. "Ultrasound contrast agent mediated transendothelial drug delivery." In International Congress on Ultrasonics. Vienna University of Technology, 2007. http://dx.doi.org/10.3728/icultrasonics.2007.vienna.1400_kooiman.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

10

Dhanaliwala, Ali H., Johnny L. Chen, Joseph P. Kilroy, Linsey C. Phillips, Adam J. Dixon, Alexander L. Klibanov, Brian R. Wamhoff, and John A. Hossack. "Intravascular ultrasound-based imaging and drug delivery." In 2013 IEEE International Ultrasonics Symposium (IUS). IEEE, 2013. http://dx.doi.org/10.1109/ultsym.2013.0292.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Ми пропонуємо знижки на всі преміум-плани для авторів, чиї праці увійшли до тематичних добірок літератури. Зв'яжіться з нами, щоб отримати унікальний промокод!